cismelnews

• H43-A2, Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline—Second Edition
• H42-A2, Enumeration of Immunologically Defined Cell Populations by Flow Cytometry; Approved Guideline—Second Edition
• M41-P, Viral Culture; Proposed Guideline
• POCT4-A2, Point-of-Care In Vitro Diagnostic (IVD) Testing; Approved Guideline—Second Edition
• POCT1-A2, Point-of-Care Connectivity; Approved Standard–-Second Edition
• AUTO10-P, Autoverification of Clinical Laboratory Test Results; Proposed Guideline
• AUTO11-P, IT Security of In Vitro Diagnostic Instruments and Software Systems; Proposed Standard
• C24-A3, Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions; Approved Guideline—Third Edition
• H20-A2, Reference Leukocyte Differential Count (Proportional) and Evaluation of Instrumental Methods; Approved Standard—Second Edition

www.clsi.org